Join
Live feed
·
INSIDERFilingvia Quantisnow
Aadi Bioscience Inc. logo

CHIEF EXECUTIVE OFFICER Lennon David James converted options into 32,558 shares and sold $18,797 worth of shares (9,689 units at $1.94) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AADI· Aadi Bioscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AADI (Aadi Bioscience Inc.) and more on Quantisnow.